Antibody-mediated delivery of IL-10 inhibits the progression of established collagen-induced arthritis

The antibody-mediated targeted delivery of cytokines to sites of disease is a promising avenue for cancer therapy, but it is largely unexplored for the treatment of chronic inflammatory conditions. Using both radioactive and fluorescent techniques, the human monoclonal antibodies L19 and G11 (specif...

Descripción completa

Detalles Bibliográficos
Autores principales: Trachsel, Eveline, Bootz, Frank, Silacci, Michela, Kaspar, Manuela, Kosmehl, Hartwig, Neri, Dario
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2007
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1860067/
https://www.ncbi.nlm.nih.gov/pubmed/17261171
http://dx.doi.org/10.1186/ar2115

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1860067/
https://www.ncbi.nlm.nih.gov/pubmed/17261171
http://dx.doi.org/10.1186/ar2115

Ejemplares similares